Estradiol Insert
FDA Label NDC 53746-226

48 label sections · Submitted to the FDA by Amneal Pharmaceuticals Of New York Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amneal Pharmaceuticals Of New York Llc for the product Estradiol (NDC 53746-226). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: endometrial cancer, cardiovascular disorders, probable dementia, and breast cancer, 2  dosage and administration, 2.1 treatment of atrophic vaginitis due to menopause, 3  dosage forms and strengths, 4  contraindications, 5.1 risks from systemic absorption, 5.2 cardiovascular disorders, 5.3 malignant neoplasms, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.